Compare Ascendis Pharma A/S (ASND) vs Reddit Inc (RDDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Reddit Inc — how do they compare? Ascendis Pharma A/S trades at $254.87 (market cap $16.67B), while Reddit Inc trades at $153.73 (market cap $30.05B). The key difference: Reddit Inc is the larger of the two by market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Reddit Inc nearer its low. Which is the better fit depends on your goals.
| ASND | RDDT | |
|---|---|---|
Market Cap | $16.67B | $30.05B |
Sector | Health | Media |
52-Week High | $277.18 | $270.71 |
52-Week Low | $189.74 | $121.84 |
Enterprise Value | $17.04B | $27.28B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ascendis Pharma (ASND) trades at $255.17, down slightly by 0.18% on the day, while maintaining strong analyst support with 92% buy ratings and a $309.75 consensus price target. The company shows impressive revenue growth from $51M in 2022 to $720M in 2025, with profitability improving as net loss narrows to -$228M. Recent technical indicators show a bullish trend with the stock trading near resistance at $255-257, while fundamental metrics reveal high valuation ratios (P/E 29.05, P/S 15.68) offset by exceptional gross margins of 89.04%.
ASND presents a compelling growth story with multiple product launches in rare endocrine diseases driving revenue expansion, though investors face risks from negative shareholder equity and high debt levels. The company's transition to positive operating cash flow ($54M in 2025) and inclusion in Russell indexes signal maturation, but execution risks remain as the stock trades at premium valuations requiring continued strong performance to justify current levels.
Reddit (RDDT) trades at $154.14, down 2.87% over 24 hours, amid bearish technical signals despite strong fundamentals. The stock shows robust revenue growth, with Q2 2026 earnings beating estimates by 31.6% and a net income margin of 31.35%. Recent news highlights CEO stock sales and AI integration efforts, while technical indicators point to resistance near $160.
Outlook remains positive based on analyst consensus with a $220.25 price target, though risks include search traffic volatility and competitive pressures. The stock's current valuation offers potential upside if user monetization and AI initiatives drive future earnings, but investors should monitor quarterly performance for sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →
